Zydus Lifesciences Drug Patent Portfolio

Zydus Lifesciences's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Indian Pharmaceutical Companies Set to Introduce Generic Semaglutide Following Ozempic Patent Expiration

17 Mar, 2026

The expiration of the patent will allow for the introduction of Semaglutide generics at prices that are 25% of the current rates.

17 Mar, 2026

Novo Nordisk dismisses the possibility of a price war with the introduction of semaglutide generics in India - Business Standard

17 Mar, 2026

India's struggle against evergreening: The year 2026 could put the drug patent system to the test - Business Standard

15 Mar, 2026